The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. Review uri icon

Overview

abstract

  • Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic affecting all levels of health systems. This includes the care of patients with noncommunicable diseases (NCDs) who bear a disproportionate burden of both COVID-19 itself and the public health measures enacted to combat it. In this review, we summarize major COVID-19-related considerations for NCD patients and their care providers, focusing on cardiovascular, pulmonary, renal, haematologic, oncologic, traumatic, obstetric/gynaecologic, operative, psychiatric, rheumatologic/immunologic, neurologic, gastrointestinal, ophthalmologic and endocrine disorders. Additionally, we offer a general framework for categorizing the pandemic's disruptions by disease-specific factors, direct health system factors and indirect health system factors. We also provide references to major NCD medical specialty professional society statements and guidelines on COVID-19. COVID-19 and its control policies have already resulted in major disruptions to the screening, treatment and surveillance of NCD patients. In addition, it differentially impacts those with pre-existing NCDs and may lead to de novo NCD sequelae. Likely, there will be long-term effects from this pandemic that will continue to affect practitioners and patients in this field for years to come.

publication date

  • October 27, 2020

Research

keywords

  • COVID-19
  • Communicable Disease Control
  • Noncommunicable Diseases
  • Patient Care Management

Identity

PubMed Central ID

  • PMC7675448

Scopus Document Identifier

  • 85093949249

Digital Object Identifier (DOI)

  • 10.1111/joim.13184

PubMed ID

  • 33020988

Additional Document Info

volume

  • 289

issue

  • 4